Wim Maes

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

Hilko Ardon, Stefaan W. Van Gool, Tina Verschuere et al. · Cancer Immunology Immunotherapy · 2012 · 157 citations · Full text

Neuro-oncology, Cancer Immunosurveillance, Medicine +8

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

Hilko Ardon, Stefaan Van Gool, Isabel Spencer Lopes et al. · Journal of Neuro-Oncology · 2010 · 143 citations

Neuro-oncology, Radiation Oncology, Cancer Immunosurveillance +13

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon et al. · Nature Communications · 2020 · 135 citations · Full text

Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells

Wim Maes, John Van Camp, Vanessa Vermeirssen et al. · Regulatory Peptides · 2004 · 109 citations

Inflammation, Molecular Physiology, Angiogenesis +11

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma

Wim Maes, Georgina Galicia, Bert Verbinnen et al. · Neuro-Oncology · 2009 · 105 citations · Full text

Dendritic Cell, Immunology, High-grade Gliomas +18